Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 18:57:07 UTC |
---|
Update Date | 2021-09-26 23:14:26 UTC |
---|
HMDB ID | HMDB0257854 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate |
---|
Description | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate, also known as {15-methyl-14-oxotetracyclo[8.7.0.0,.0,]heptadeca-2(7),3-dien-5-yl}oxidanesulfonate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. Based on a literature review very few articles have been published on [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate. This compound has been identified in human blood as reported by (PMID: 31557052 ). [(8r,9s,13s,14s)-13-methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3h-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CC12CCC3C(CCC4=C3C=CC(C4)OS(O)(=O)=O)C1CCC2=O InChI=1S/C18H24O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,12,14-16H,2,4,6-10H2,1H3,(H,20,21,22) |
---|
Synonyms | Value | Source |
---|
[(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfuric acid | Generator | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulphate | Generator | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulphuric acid | Generator | {15-methyl-14-oxotetracyclo[8.7.0.0,.0,]heptadeca-2(7),3-dien-5-yl}oxidanesulfonate | HMDB | {15-methyl-14-oxotetracyclo[8.7.0.0,.0,]heptadeca-2(7),3-dien-5-yl}oxidanesulphonate | HMDB | {15-methyl-14-oxotetracyclo[8.7.0.0,.0,]heptadeca-2(7),3-dien-5-yl}oxidanesulphonic acid | HMDB |
|
---|
Chemical Formula | C18H24O5S |
---|
Average Molecular Weight | 352.45 |
---|
Monoisotopic Molecular Weight | 352.134445047 |
---|
IUPAC Name | {15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3-dien-5-yl}oxidanesulfonic acid |
---|
Traditional Name | {15-methyl-14-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3-dien-5-yl}oxidanesulfonic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC12CCC3C(CCC4=C3C=CC(C4)OS(O)(=O)=O)C1CCC2=O |
---|
InChI Identifier | InChI=1S/C18H24O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,12,14-16H,2,4,6-10H2,1H3,(H,20,21,22) |
---|
InChI Key | LWIWLIRCYGKRAH-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Sulfated steroids |
---|
Direct Parent | Sulfated steroids |
---|
Alternative Parents | |
---|
Substituents | - Sulfated steroid skeleton
- Oxosteroid
- 17-oxosteroid
- Sulfuric acid ester
- Alkyl sulfate
- Sulfate-ester
- Sulfuric acid monoester
- Organic sulfuric acid or derivatives
- Ketone
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
[(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate | CC12CCC3C(CCC4=C3C=CC(C4)OS(O)(=O)=O)C1CCC2=O | 4331.0 | Standard polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate | CC12CCC3C(CCC4=C3C=CC(C4)OS(O)(=O)=O)C1CCC2=O | 2618.4 | Standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate | CC12CCC3C(CCC4=C3C=CC(C4)OS(O)(=O)=O)C1CCC2=O | 3095.6 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
[(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TMS,isomer #1 | CC12CCC3C4=C(CCC3C1CCC2=O)CC(OS(=O)(=O)O[Si](C)(C)C)C=C4 | 3104.3 | Semi standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TMS,isomer #1 | CC12CCC3C4=C(CCC3C1CCC2=O)CC(OS(=O)(=O)O[Si](C)(C)C)C=C4 | 2982.7 | Standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TMS,isomer #1 | CC12CCC3C4=C(CCC3C1CCC2=O)CC(OS(=O)(=O)O[Si](C)(C)C)C=C4 | 3805.2 | Standard polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TMS,isomer #2 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C)CC(OS(=O)(=O)O)C=C4 | 3109.0 | Semi standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TMS,isomer #2 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C)CC(OS(=O)(=O)O)C=C4 | 2804.4 | Standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TMS,isomer #2 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C)CC(OS(=O)(=O)O)C=C4 | 3858.7 | Standard polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,2TMS,isomer #1 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C)CC(OS(=O)(=O)O[Si](C)(C)C)C=C4 | 3121.0 | Semi standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,2TMS,isomer #1 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C)CC(OS(=O)(=O)O[Si](C)(C)C)C=C4 | 3025.7 | Standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,2TMS,isomer #1 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C)CC(OS(=O)(=O)O[Si](C)(C)C)C=C4 | 3806.8 | Standard polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TBDMS,isomer #1 | CC12CCC3C4=C(CCC3C1CCC2=O)CC(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)C=C4 | 3340.6 | Semi standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TBDMS,isomer #1 | CC12CCC3C4=C(CCC3C1CCC2=O)CC(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)C=C4 | 3294.5 | Standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TBDMS,isomer #1 | CC12CCC3C4=C(CCC3C1CCC2=O)CC(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)C=C4 | 3950.1 | Standard polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TBDMS,isomer #2 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C(C)(C)C)CC(OS(=O)(=O)O)C=C4 | 3372.1 | Semi standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TBDMS,isomer #2 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C(C)(C)C)CC(OS(=O)(=O)O)C=C4 | 3078.4 | Standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,1TBDMS,isomer #2 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C(C)(C)C)CC(OS(=O)(=O)O)C=C4 | 4025.5 | Standard polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,2TBDMS,isomer #1 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C(C)(C)C)CC(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)C=C4 | 3583.5 | Semi standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,2TBDMS,isomer #1 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C(C)(C)C)CC(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)C=C4 | 3571.9 | Standard non polar | 33892256 | [(8R,9S,13S,14S)-13-Methyl-17-oxo-4,6,7,8,9,11,12,14,15,16-decahydro-3H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,2TBDMS,isomer #1 | CC12CCC3C4=C(CCC3C1CC=C2O[Si](C)(C)C(C)(C)C)CC(OS(=O)(=O)O[Si](C)(C)C(C)(C)C)C=C4 | 4002.6 | Standard polar | 33892256 |
| Show more...
---|